AER001

Status : investigational

Description

AER001, an IL4/13 receptor antagonist for severe asthma and eczema currently in Phase 2 studies.

Used

Investigated for use/treatment in asthma.

Chemical Classification

Calculated Property

kind Value Source

Target within organism

  • Interleukin-4 receptor subunit alpha : in Human
  • Interleukin-13 receptor subunit alpha-2 : in Human